Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Claesson

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Scandinavian Journal of Immunology|January 25, 2003
Self-peptides with intermediate capacity to bind and stabilize MHC class I molecules may be immunogenicM L M Andersen, M Ruhwald, M H Nissen, et al.
Scandinavian Journal of Immunology|September 26, 2003
Immunobiological effects of glucosamine in vitroL Forchhammer, M Thorn, O Met, et al.
Clinical and Experimental Immunology|February 18, 2009
High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4+ T cell responses more than 30 years post-vaccinia virus vaccinationM Wang, S T Tang, O Lund, et al.
Scandinavian Journal of Immunology|December 12, 2007
Cellular expression or binding of desLys58-beta2 microglobulin is not dependent on the presence of the tri-molecular MHC class I complexM Wang, D B Corlin, N H H Heegaard, et al.
European Journal of Immunology|December 1, 1996
Cytotoxic reactivity of gut lamina propria CD4+ alpha beta T cells in SCID mice with colitisK Bonhagen, S Thoma, P Bland, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 22, 2006
Vaccination with melanoma lysate-pulsed dendritic cells, of patients with advanced colorectal carcinoma: report from a phase I studyS K Burgdorf, A Fischer, M H Claesson, et al.
Scandinavian Journal of Immunology|April 4, 2001
Identification and design of p53-derived HLA-A2-binding peptides with increased CTL immunogenicityT R Petersen, S Buus, S Brunak, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 25, 2001
Transforming growth factor-beta messenger RNA and protein in murine colitisC V Whiting, A M Williams, M H Claesson, et al.
Immunology|April 13, 2007
Tolerogenic dendritic cells pulsed with enterobacterial extract suppress development of colitis in the severe combined immunodeficiency transfer modelA E Pedersen, M Gad, N N Kristensen, et al.
Scandinavian Journal of Immunology|January 29, 2000
Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 proteinA M Barfoed, T R Petersen, A F Kirkin, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Scandinavian Journal of Immunology|January 25, 2003
Self-peptides with intermediate capacity to bind and stabilize MHC class I molecules may be immunogenicM L M Andersen, M Ruhwald, M H Nissen, et al.
Scandinavian Journal of Immunology|September 26, 2003
Immunobiological effects of glucosamine in vitroL Forchhammer, M Thorn, O Met, et al.
Clinical and Experimental Immunology|February 18, 2009
High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4+ T cell responses more than 30 years post-vaccinia virus vaccinationM Wang, S T Tang, O Lund, et al.
Scandinavian Journal of Immunology|December 12, 2007
Cellular expression or binding of desLys58-beta2 microglobulin is not dependent on the presence of the tri-molecular MHC class I complexM Wang, D B Corlin, N H H Heegaard, et al.
European Journal of Immunology|December 1, 1996
Cytotoxic reactivity of gut lamina propria CD4+ alpha beta T cells in SCID mice with colitisK Bonhagen, S Thoma, P Bland, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 22, 2006
Vaccination with melanoma lysate-pulsed dendritic cells, of patients with advanced colorectal carcinoma: report from a phase I studyS K Burgdorf, A Fischer, M H Claesson, et al.
Scandinavian Journal of Immunology|April 4, 2001
Identification and design of p53-derived HLA-A2-binding peptides with increased CTL immunogenicityT R Petersen, S Buus, S Brunak, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 25, 2001
Transforming growth factor-beta messenger RNA and protein in murine colitisC V Whiting, A M Williams, M H Claesson, et al.
Immunology|April 13, 2007
Tolerogenic dendritic cells pulsed with enterobacterial extract suppress development of colitis in the severe combined immunodeficiency transfer modelA E Pedersen, M Gad, N N Kristensen, et al.
Scandinavian Journal of Immunology|January 29, 2000
Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 proteinA M Barfoed, T R Petersen, A F Kirkin, et al.
Pageof 12